SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-05-000788
Filing Date
2005-01-27
Accepted
2005-01-27 16:10:43
Documents
2
Period of Report
2005-01-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICALS, INC. y05190e8vk.txt 8-K 4175
2 CONSULTING AGREEMENT y05190exv10w1.txt EX-10.1 9984
  Complete submission text file 0000950123-05-000788.txt   16124
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 05554001
SIC: 2835 In Vitro & In Vivo Diagnostic Substances